FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A Win for Molecularly Guided Therapy for Cancer of Unknown Primary

2.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

3.

In early dementia, SSRIs enhance cognition and major depression.

4.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

5.

Patients face high out-of-pocket costs after incident cancer diagnosis


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot